Phase III study of telisotuzumab vedotin (Teliso-V) vs docetaxel in pretreated c-Met overexpressing EGFR wildtype (WT) non-squamous (NSQ) locally advanced/ metastatic nonsmall cell lung cancer (a/mNSCLC)

Tanizaki, J.; Akamatsu, H.; Su, J.; Lee, G-W.; Xia, M. S.; Ainsworth, B.; Li, M.; Bolotin, E.; Seraj, J.; Lu, S.

doi:10.1016/j.annonc.2023.10.678

상세 보기

Phase III study of telisotuzumab vedotin (Teliso-V) vs docetaxel in pretreated c-Met overexpressing EGFR wildtype (WT) non-squamous (NSQ) locally advanced/ metastatic nonsmall cell lung cancer (a/mNSCLC)

Tanizaki, J.;
Akamatsu, H.;
Su, J.;
Lee, G-W.;
Xia, M. S.;
외 5명

Citations

WEB OF SCIENCE

1

Citations

SCOPUS

0

제목: Phase III study of telisotuzumab vedotin (Teliso-V) vs docetaxel in pretreated c-Met overexpressing EGFR wildtype (WT) non-squamous (NSQ) locally advanced/ metastatic nonsmall cell lung cancer (a/mNSCLC)

저자: Tanizaki, J.; Akamatsu, H.; Su, J.; Lee, G-W.; Xia, M. S.; Ainsworth, B.; Li, M.; Bolotin, E.; Seraj, J.; Lu, S.

DOI: 10.1016/j.annonc.2023.10.678

발행일: 2023-11

유형: Meeting Abstract

저널명: Annals of Oncology

권: 34

페이지: S1705 ~ S1706

ScholarWorks@경상국립대학교

상세 보기